Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Macy's Inc (M) vs Tilray Brands Inc (TLRY) Price & Performance

Macy's IncTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Macy's Inc vs Tilray Brands Inc — how do they compare? Macy's Inc trades at $23.64 (market cap $6.13B), while Tilray Brands Inc trades at $4.23 (market cap $524.07M). The key difference: Macy's Inc is far larger — about 11.7× Tilray Brands Inc's market cap, and Macy's Inc pays a 3.29% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

MTLRY
Market Cap
$6.13B$524.07M
Sector
Consumer CyclicalHealth
52-Week High
$25.96$21.00
52-Week Low
$11.90$4.23
Enterprise Value
$9.95B$621.22M
Dividend Yield
3.29%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Macy's Inc

Macy's (M) trades at $23.39, down 1.22% on the day, with a bullish technical signal supported by moving averages. The stock shows attractive valuation metrics including a P/E of 9.79 and P/S of 0.29, while recent earnings have consistently beaten expectations. Positive sentiment is driven by the 'Bold New Chapter' turnaround strategy, with Berkshire Hathaway's new 3.04 million-share position adding institutional confidence.

The outlook remains cautiously optimistic with a consensus price target of $24.83 offering 6% upside potential. Key opportunities include luxury brand expansion and digital transformation, while risks involve margin pressure from store closures and macroeconomic sensitivity. The stock presents value characteristics with growth catalysts from operational improvements.

Tilray Brands Inc

TLRY trades at $4.23, down 1.63% with bearish technical signals. The company reported revenue growth to $821.31M in 2025 but faces severe profitability challenges with a net loss of $2.19B and negative margins. Recent expansion includes medical cannabis launches in Panama and strategic acquisitions, while analyst consensus shows cautious sentiment with 65% hold ratings.

The outlook remains challenging due to persistent losses and high debt levels, though expansion initiatives and potential regulatory changes offer long-term opportunities. Key risks include execution on profitability, competitive pressures, and cannabis regulatory uncertainty.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Macy's Inc

Founded in 1858 and based in New York City, Macy's operates 570 stores under the Macy's nameplate, 58 stores under the Bloomingdale's nameplate, and 160 freestanding Bluemercury specialty beauty stores (as of the end of fiscal-year 2021). Macy's also operates e-commerce sites and licenses two Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances comprised 59% of Macy's 2021 sales.

Read more on M

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY